1. Home
  2. ETON vs TATT Comparison

ETON vs TATT Comparison

Compare ETON & TATT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETON
  • TATT
  • Stock Information
  • Founded
  • ETON 2017
  • TATT 1985
  • Country
  • ETON United States
  • TATT Israel
  • Employees
  • ETON N/A
  • TATT N/A
  • Industry
  • ETON Biotechnology: Pharmaceutical Preparations
  • TATT Aerospace
  • Sector
  • ETON Health Care
  • TATT Industrials
  • Exchange
  • ETON Nasdaq
  • TATT Nasdaq
  • Market Cap
  • ETON 428.5M
  • TATT 308.2M
  • IPO Year
  • ETON 2018
  • TATT 1987
  • Fundamental
  • Price
  • ETON $17.21
  • TATT $34.58
  • Analyst Decision
  • ETON Strong Buy
  • TATT Strong Buy
  • Analyst Count
  • ETON 3
  • TATT 1
  • Target Price
  • ETON $27.67
  • TATT $35.00
  • AVG Volume (30 Days)
  • ETON 221.4K
  • TATT 137.7K
  • Earning Date
  • ETON 05-13-2025
  • TATT 05-21-2025
  • Dividend Yield
  • ETON N/A
  • TATT N/A
  • EPS Growth
  • ETON N/A
  • TATT 96.08
  • EPS
  • ETON N/A
  • TATT 1.00
  • Revenue
  • ETON $39,011,000.00
  • TATT $152,116,000.00
  • Revenue This Year
  • ETON $92.33
  • TATT $18.62
  • Revenue Next Year
  • ETON $52.62
  • TATT $10.62
  • P/E Ratio
  • ETON N/A
  • TATT $31.80
  • Revenue Growth
  • ETON 23.29
  • TATT 33.68
  • 52 Week Low
  • ETON $3.18
  • TATT $11.84
  • 52 Week High
  • ETON $18.41
  • TATT $33.83
  • Technical
  • Relative Strength Index (RSI)
  • ETON 70.21
  • TATT 73.45
  • Support Level
  • ETON $16.43
  • TATT $28.58
  • Resistance Level
  • ETON $17.49
  • TATT $33.83
  • Average True Range (ATR)
  • ETON 0.85
  • TATT 1.82
  • MACD
  • ETON 0.18
  • TATT 0.75
  • Stochastic Oscillator
  • ETON 98.09
  • TATT 91.55

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

About TATT TAT Technologies Ltd.

TAT Technologies Ltd provides solutions and services to the commercial and military aerospace and ground defense industries, focused mainly on three product areas and services: Thermal Management, Power and Actuation, and Maintenance, Repair and Overhaul (MRO). Its product portfolio includes heat exchangers, cooling systems, and mechanical aircraft accessories and systems such as pumps, valves, and turbine power units. Its operating segments are MRO services for aviation components, which derive key revenue, Original equipment manufacturing (OEM) of heat transfer solutions and aviation accessories, MRO services for heat transfer components and OEM of heat transfer solutions, and Overhaul and coating of jet engine components. Geographically, it derives key revenue from the United States.

Share on Social Networks: